Provided by Tiger Trade Technology Pte. Ltd.

Park National

173.86
-3.0600-1.73%
Volume:53.07K
Turnover:9.26M
Market Cap:3.14B
PE:15.65
High:177.20
Open:176.72
Low:172.87
Close:176.92
52wk High:179.48
52wk Low:137.97
Shares:18.07M
Float Shares:15.22M
Volume Ratio:0.66
T/O Rate:0.35%
Dividend:4.28
Dividend Rate:2.46%
EPS(TTM):11.11
EPS(LYR):11.11
ROE:13.87%
ROA:1.84%
PB:2.32
PE(LYR):15.65

Loading ...

Park National Bank to Buy First Citizens in $317M Deal

Dow Jones
·
Oct 28, 2025

Park National Announces Merger with First Citizens

TIPRANKS
·
Oct 28, 2025

Park Ntl Q3 Adj. EPS $2.87 Beats $2.73 Estimate, Sales $141.591M Beat $140.276M Estimate

Benzinga
·
Oct 28, 2025

Park National Q3 net income rises 23.4% on robust loan growth

Reuters
·
Oct 28, 2025

BRIEF-Park National Bank Welcomes First Citizens National Bank In Strategic Partnership

Reuters
·
Oct 28, 2025

BRIEF-Park National Corporation Reports Financial Results For Third Quarter And First Nine Months Of 2025

Reuters
·
Oct 28, 2025

Park National: Deal Valued at $317.3 Mln, Fizn Share Price $82.96

THOMSON REUTERS
·
Oct 28, 2025

Park National Corp - Park Will Issue Approximately 1.99 Mln Shares to Acquire Fizn in an All-Stock Transaction

THOMSON REUTERS
·
Oct 28, 2025

Park National: First Citizens' CEO, Jeff Agee, to Lead New Tennessee Region of Park National Bank

THOMSON REUTERS
·
Oct 28, 2025

BRIEF-Park National Q3 EPS USD 2.92

Reuters
·
Oct 28, 2025

Park National Q3 Basic EPS USD 2.93

THOMSON REUTERS
·
Oct 28, 2025

Park National Corp - Declared Special One-Time Dividend of $1.25 per Common Share

THOMSON REUTERS
·
Oct 28, 2025

Park National Q3 Net Interest Margin 4.72%

THOMSON REUTERS
·
Oct 28, 2025

Park National Q3 Pretax Profit USD 58.098 Million

THOMSON REUTERS
·
Oct 28, 2025

Park National Corporation Reports Financial Results for Third Quarter and First Nine Months of 2025

THOMSON REUTERS
·
Oct 28, 2025

Opus Genetics Doses First Patient in Pivotal LYNX-3 Phase 3 Trial Evaluating Phentolamine Ophthalmic Solution 0.75% in Keratorefractive Patients With Visual Disturbances Under Mesopic, Low-Contrast Conditions

GlobeNewswire
·
Sep 04, 2025